Clinicopathologic significance of DNA methyltransferase 1, 3a, and 3b overexpression in Tunisian breast cancers
Authors:
- Mohamed HachanaMHMohamed Hachana
- Sonia ZiadiSZSonia Ziadi
- Soumaya Ben AbdelkarimSASoumaya Ben Abdelkarim
- Samir HidarSHSamir Hidar
- Mounir TrimecheMTMounir Trimeche
- 1 October 2012
- journal article
- Published by Elsevier in Human Pathology
- Vol. 43 (10) , 1731-1738
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumorsHuman Pathology, 2010
- The Expression and Clinical Significance of DNA Methyltransferase Proteins in Human Gastric CancerDigestive Diseases and Sciences, 2008
- DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell linesMolecular Cancer, 2008
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- The DNA methyltransferases of mammalsHuman Molecular Genetics, 2000
- Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and FinlandNew England Journal of Medicine, 2000
- DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian DevelopmentCell, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- DNA methyltransferasesCurrent Opinion in Cell Biology, 1994